Literature DB >> 2078820

Genetic correlations among inbred strain sensitivities to convulsions induced by 9 convulsant drugs.

A E Kosobud1, J C Crabbe.   

Abstract

Inbred mouse strains differed significantly in sensitivity to convulsions induced by 9 convulsant drugs administered using a timed infusion procedure. Some strains (e.g. BALB/cJ, A/J) were generally seizure-susceptible, while some were generally seizure resistant (e.g. C57BL/6J, SWR/J). However, the overall pattern of strain sensitivities was complex, and depended upon drug and convulsant sign. Five of the drugs (bicuculline, DMCM, picrotoxin, TBPS and pentylenetetrazol (PTZ] produce convulsions, at least in part, through their interactions with the GABA receptor, while the other 4 (strychnine, CHEB, 4-aminopyridine and kainic acid) act through independent mechanisms. We predicted that responses to drugs with similar mechanisms of action would be genetically correlated. However, strains sensitive to picrotoxin-induced convulsions were not necessarily sensitive to convulsions elicited by PTZ or TBPS. Furthermore, different convulsant signs produced by a single drug were not always strongly correlated. Instead, genetic correlations were found among inbred strains for sensitivity to similar convulsant signs produced by different drugs. This suggests that genetic variation in sensitivity to these convulsant drugs arises primarily from variation in systems important for the expression of the convulsion.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2078820     DOI: 10.1016/0006-8993(90)90243-5

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  30 in total

Review 1.  The relevance of individual genetic background and its role in animal models of epilepsy.

Authors:  P Elyse Schauwecker
Journal:  Epilepsy Res       Date:  2011-10-15       Impact factor: 3.045

Review 2.  Genetic influences on ketogenic diet efficacy.

Authors:  Stacey B B Dutton; Andrew Escayg
Journal:  Epilepsia       Date:  2008-11       Impact factor: 5.864

3.  Does electroencephalogram phase variability account for reduced P3 brain potential in externalizing disorders?

Authors:  Scott J Burwell; Stephen M Malone; Edward M Bernat; William G Iacono
Journal:  Clin Neurophysiol       Date:  2014-03-06       Impact factor: 3.708

4.  Comparative analysis of seizures induced by intracerebroventricular administration of NMDA, kainate and quisqualate in mice.

Authors:  C Mathis; A Ungerer
Journal:  Exp Brain Res       Date:  1992       Impact factor: 1.972

5.  Zimelidine decreases seizure susceptibility in stressed mice.

Authors:  D Pericić; D S Strac; J Vlainić
Journal:  J Neural Transm (Vienna)       Date:  2006-06-01       Impact factor: 3.575

6.  Mapping loci for pentylenetetrazol-induced seizure susceptibility in mice.

Authors:  T N Ferraro; G T Golden; G G Smith; P St Jean; N J Schork; N Mulholland; C Ballas; J Schill; R J Buono; W H Berrettini
Journal:  J Neurosci       Date:  1999-08-15       Impact factor: 6.167

7.  Dissociation of seizure traits in inbred strains of mice using the flurothyl kindling model of epileptogenesis.

Authors:  Dominick Papandrea; Tara M Anderson; Bruce J Herron; Russell J Ferland
Journal:  Exp Neurol       Date:  2008-10-07       Impact factor: 5.330

8.  A mouse mutant strain highly resistant to methyl beta-carboline-3-carboxylate-induced seizures.

Authors:  Y Clément; J M Launay; D Bondoux; P Venault; B Martin; J Young; P Robel; G Chapouthier
Journal:  Exp Brain Res       Date:  1996-06       Impact factor: 1.972

9.  Dynamin 1 isoform roles in a mouse model of severe childhood epileptic encephalopathy.

Authors:  Samuel Asinof; Connie Mahaffey; Barbara Beyer; Wayne N Frankel; Rebecca Boumil
Journal:  Neurobiol Dis       Date:  2016-06-28       Impact factor: 5.996

10.  Sedative and anticonvulsant effects of zolpidem in adult and aged mice.

Authors:  Danka Pericić; Josipa Vlainić; Dubravka Svob Strac
Journal:  J Neural Transm (Vienna)       Date:  2008-01-24       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.